45 related articles for article (PubMed ID: 38560081)
1. Assessment of post-myocardial infarction lipid levels and management: Results from a tertiary care hospital of Pakistan.
Rauf R; Soomro MI; Khan MN; Kumar M; Soomro NA; Kazmi KA
World J Cardiol; 2024 May; 16(5):282-292. PubMed ID: 38817645
[TBL] [Abstract][Full Text] [Related]
2. Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.
Rosenblit PD
Curr Diab Rep; 2019 Nov; 19(12):146. PubMed ID: 31754844
[TBL] [Abstract][Full Text] [Related]
3. New recommendations from the 1999 American College of Cardiology/American Heart Association acute myocardial infarction guidelines.
Spinler SA; Hilleman DE; Cheng JW; Howard PA; Mauro VF; Lopez LM; Munger MA; Gardner SF; Nappi JM
Ann Pharmacother; 2001 May; 35(5):589-617. PubMed ID: 11346067
[TBL] [Abstract][Full Text] [Related]
4. Application of the very high risk criterion and evaluation of cholesterol guideline adherence in acute myocardial infarction patients at an urban academic medical center.
Brownstein AJ; Derenbecker R; Gao Y; Ding J; Varghese B; Isakadze N; Spaulding EM; Marvel FA; Martin SS
Am Heart J Plus; 2022 Jan; 13():100082. PubMed ID: 38560081
[TBL] [Abstract][Full Text] [Related]
5. LOGAN-CV: A Prospective Study of a Multifaceted Intervention Targeting United States Clinicians to Improve Guideline-Based Management of Lipid-Lowering Therapy.
McKoy JN; Kalich BA; Greene L; Mackey RH; Rosenthal NA; Khan Y; Wójcik C; Jones J; Carabuena LA
Adv Ther; 2024 Jan; 41(1):451-463. PubMed ID: 37989909
[TBL] [Abstract][Full Text] [Related]
6. Moderate-Intensity Statin With Ezetimibe Combination Therapy vs High-Intensity Statin Monotherapy in Patients at Very High Risk of Atherosclerotic Cardiovascular Disease: A Post Hoc Analysis From the RACING Randomized Clinical Trial.
Lee SJ; Cha JJ; Choi WG; Lee WS; Jeong JO; Choi S; Cho YH; Park W; Yoon CH; Lee YJ; Hong SJ; Ahn CM; Kim BK; Ko YG; Choi D; Hong MK; Jang Y; Hong SJ; Kim JS;
JAMA Cardiol; 2023 Sep; 8(9):853-858. PubMed ID: 37531130
[TBL] [Abstract][Full Text] [Related]
7. A Retrospective Study on the Adoption of Lipid Management Guidelines in Post-Myocardial Infarction Patients in a Tertiary Care Centre.
Wambua PM; Khan Z; Kariuki CM; Ogola EN
Cureus; 2023 Jul; 15(7):e41402. PubMed ID: 37546064
[TBL] [Abstract][Full Text] [Related]
8. Dyslipidemia treatment and attainment of LDL-cholesterol treatment goals in patients participating in the Managed Care for Acute Myocardial Infarction Survivors program.
Nowowiejska-Wiewióra A; Wita K; Mędrala Z; Tomkiewicz-Pająk L; Bujak K; Mizia-Stec K; Brzychczy P; Gąsior M; Gąsior Z; Kulbat A; Kalarus Z; Wojakowski W; Trzeciak P; Witkowski A; Banach M; Legutko J
Kardiol Pol; 2023; 81(4):359-365. PubMed ID: 36871294
[TBL] [Abstract][Full Text] [Related]
9. Digital Health Intervention in Acute Myocardial Infarction.
Marvel FA; Spaulding EM; Lee MA; Yang WE; Demo R; Ding J; Wang J; Xun H; Shah LM; Weng D; Carter J; Majmudar M; Elgin E; Sheidy J; McLin R; Flowers J; Vilarino V; Lumelsky DN; Bhardwaj V; Padula WV; Shan R; Huynh PP; Wongvibulsin S; Leung C; Allen JK; Martin SS
Circ Cardiovasc Qual Outcomes; 2021 Jul; 14(7):e007741. PubMed ID: 34261332
[TBL] [Abstract][Full Text] [Related]
10. Use of Lipid-Lowering Therapies Over 2 Years in GOULD, a Registry of Patients With Atherosclerotic Cardiovascular Disease in the US.
Cannon CP; de Lemos JA; Rosenson RS; Ballantyne CM; Liu Y; Gao Q; Palagashvilli T; Alam S; Mues KE; Bhatt DL; Kosiborod MN;
JAMA Cardiol; 2021 Jun; 6(9):1-9. PubMed ID: 34132735
[TBL] [Abstract][Full Text] [Related]
11. Low-Density Lipoprotein Cholesterol and Adverse Cardiovascular Events After Percutaneous Coronary Intervention.
Sud M; Han L; Koh M; Abdel-Qadir H; Austin PC; Farkouh ME; Godoy LC; Lawler PR; Udell JA; Wijeysundera HC; Ko DT
J Am Coll Cardiol; 2020 Sep; 76(12):1440-1450. PubMed ID: 32943162
[TBL] [Abstract][Full Text] [Related]
12. More accurate LDL-C calculation: Externally validated, guideline endorsed.
Brownstein AJ; Martin SS
Clin Chim Acta; 2020 Jul; 506():149-153. PubMed ID: 32205096
[TBL] [Abstract][Full Text] [Related]
13. Impact of Lipid Monitoring on Treatment Intensification of Cholesterol Lowering Therapies (from the Veterans Affairs Healthcare System).
Jia X; Ramsey DJ; Rifai MA; Ahmed ST; Akeroyd JM; Dixon DL; Gluckman TJ; Nambi V; Ballantyne CM; Petersen LA; Stone NJ; Virani SS
Am J Cardiol; 2020 Mar; 125(6):874-879. PubMed ID: 31952841
[TBL] [Abstract][Full Text] [Related]
14. Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes.
Roe MT; Li QH; Bhatt DL; Bittner VA; Diaz R; Goodman SG; Harrington RA; Jukema JW; Lopez-Jaramillo P; Lopes RD; Louie MJ; Moriarty PM; Szarek M; Vogel R; White HD; Zeiher AM; Baccara-Dinet MT; Steg PG; Schwartz GG
Circulation; 2019 Nov; 140(19):1578-1589. PubMed ID: 31475572
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
